Ken Griffin Hookipa Pharma Inc. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.59 - $1.04 $13,275 - $23,400
-22,500 Reduced 51.61%
21,100 $12,000
Q1 2024

May 15, 2024
BUY
$0.61 - $0.83 $26,596 - $36,188
43,600 New
43,600 $30,000
Q3 2023

Nov 14, 2023
SELL
$0.58 - $0.91 $1,218 - $1,911
-2,100 Reduced 46.67%
2,400 $1,000
Q2 2023

Aug 14, 2023
BUY
$0.71 - $1.97 $2,840 - $7,880
4,000 Added 800.0%
4,500 $3,000
Q4 2022

Feb 14, 2023
BUY
$0.73 - $14.6 $365 - $7,300
500 New
500 $0

Others Institutions Holding HOOK

# of Institutions
3
Shares Held
677K
Call Options Held
0
Put Options Held
0
View Full List

About HOOKIPA Pharma Inc.

HOOK Quotes by TradingView
  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $98.7M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email